MRVI
Maravai LifeSciences Holdings, Inc. Healthcare - Biotechnology Investor Relations →
Maravai LifeSciences Holdings, Inc. (MRVI) closed at $3.14 as of 2026-02-02, trading 69.7% below its 200-week moving average of $10.35. This places MRVI in the extreme value zone. The stock is currently moving closer to the line, down from -68.1% last week. The 14-week RSI sits at 50, indicating neutral momentum.
Over the past 224 weeks of data, MRVI has crossed below its 200-week moving average 3 times. On average, these episodes lasted 71 weeks. The average one-year return after crossing below was -58.2%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $1150 million, MRVI is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -40.9%. The stock trades at 1.9x book value.
Share count has increased 8.0% over three years, indicating dilution.
Over the past 4.4 years, a hypothetical investment of $100 in MRVI would have grown to $7, compared to $160 for the S&P 500. MRVI has returned -44.5% annualized vs 11.2% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 3 open-market purchases totaling $1,880,243. Multiple insiders purchased within a 30-day window — a cluster buy pattern that historically signals management confidence in the company's prospects. Notably, these purchases occurred while MRVI is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.
Free cash flow has been declining at a -100% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: MRVI vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After MRVI Crosses Below the Line?
Across 3 historical episodes, buying MRVI when it crossed below its 200-week moving average produced an average return of -59.0% after 12 months (median -60.0%), compared to -8.3% for the S&P 500 over the same periods. After 24 months, the average return was -81.3% vs +11.0% for the index.
Each line shows $100 invested at the moment MRVI crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
MRVI has crossed below its 200-week MA 3 times with an average 1-year return of +-58.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Nov 2021 | Nov 2021 | 3 | 9.7% | -55.7% | -91.0% |
| Jan 2022 | Feb 2022 | 8 | 36.5% | -60.6% | -90.6% |
| Mar 2022 | Ongoing | 203+ | 90.3% | Ongoing | -91.4% |
| Average | 71 | — | +-58.2% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02